About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD38.85
- USD39.91
- USD38.32
- USD62.58
- 13.50%
- 37M
- 793.60k
- 626.30k
- 2.1B
- 23.42
- -12.00%
Stock News
5 hours ago
Investors in Nestlé (Malaysia) Berhad (KLSE:NESTLE) have unfortunately lost 40% over the last five years
Yahoo
7 hours ago
Treasury Yields Snapshot: July 11, 2025
SeekingAlpha
yesterday
Trump threatens to revoke comedian Rosie O’Donnell's citizenship
CNBC
yesterday
Federal Reserve quietly responds to Trump administration attacks over renovation
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
